{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:06:20Z","timestamp":1785852380517,"version":"3.56.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1097\/01.pas.0000155154.46434.93","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T04:01:10Z","timestamp":1110772870000},"page":"452-459","source":"Crossref","is-referenced-by-count":10,"title":["Death Receptor Apoptosis Signaling Mediated by FADD in CD30-Positive Lymphoproliferative Disorders Involving the Skin"],"prefix":"10.1097","volume":"29","author":[{"given":"Loren E","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Bayerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Ioffreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Abou-Elella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus F","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2133.2001.04295.x","article-title":"CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.","volume":"145","author":"Aoki","year":"2001","journal-title":"Br J Dermatol"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand.","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.2003.04072.x","article-title":"Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas.","volume":"120","author":"Assaf","year":"2003","journal-title":"Br J Haematol"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/002215540104900703","article-title":"Advances in cytochemical methods for detection of apoptosis.","volume":"49","author":"Barrett","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology.","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood.V91.12.4668","article-title":"Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.","volume":"91","author":"Beylot-Barry","year":"1998","journal-title":"Blood"},{"key":"R8-4-20210130","first-page":"3591","article-title":"CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.","volume":"92","author":"Brugieres","year":"1998","journal-title":"Blood"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/1523-1747.ep12345532","article-title":"The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis.","volume":"106","author":"Chott","year":"1996","journal-title":"J Invest Dermatol"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":"The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.","volume":"87","author":"DeCoteau","year":"1996","journal-title":"Blood"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1359-6101(03)00021-2","article-title":"The signaling adaptors and pathways activated by TNF superfamily.","volume":"14","author":"Dempsey","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2401878","article-title":"Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.","volume":"14","author":"Drexler","year":"2000","journal-title":"Leukemia"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.1289","article-title":"Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts.","volume":"199","author":"Duan","year":"2003","journal-title":"J Pathol"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/MCB.17.3.1535","article-title":"Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.","volume":"17","author":"Duckett","year":"1997","journal-title":"Mol Cell Biol"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1074\/jbc.271.22.12852","article-title":"CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins.","volume":"271","author":"Gedrich","year":"1996","journal-title":"J Biol Chem"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/002215540205000401","article-title":"Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3.","volume":"50","author":"Gown","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)00003-9","article-title":"Apoptotic pathways: paper wraps stone blunts scissors.","volume":"102","author":"Green","year":"2000","journal-title":"Cell"},{"key":"R18-4-20210130","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V83.8.2045.2045","article-title":"Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.","volume":"83","author":"Gruss","year":"1994","journal-title":"Blood"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/sj.onc.1205337","article-title":"Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.","volume":"21","author":"Horie","year":"2002","journal-title":"Oncogene"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","article-title":"Systemic and primary cutaneous anaplastic large cell lymphomas.","volume":"40","author":"Kadin","year":"2003","journal-title":"Semin Hematol"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2001.tb03711.x","article-title":"Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand.","volume":"941","author":"Kadin","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R23-4-20210130","first-page":"3330","article-title":"Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.","volume":"61","author":"Kagawa","year":"2001","journal-title":"Cancer Res"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1600-0560.2002.290507.x","article-title":"Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.","volume":"29","author":"Kempf","year":"2002","journal-title":"J Cutan Pathol"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archderm.1997.03890430031005","article-title":"Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.","volume":"133","author":"Kikuchi","year":"1997","journal-title":"Arch Dermatol"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2002-02-0475","article-title":"Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.","volume":"101","author":"Kleinhans","year":"2003","journal-title":"Blood"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.2000.00175.x","article-title":"Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression.","volume":"115","author":"Levi","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1600-0560.2002.290803.x","article-title":"Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.","volume":"29","author":"Liang","year":"2002","journal-title":"J Cutan Pathol"},{"key":"R29-4-20210130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R30-4-20210130","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0002-9440(10)63525-0","article-title":"Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.","volume":"163","author":"Mandell","year":"2003","journal-title":"Am J Pathol"},{"key":"R31-4-20210130","first-page":"382","article-title":"Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer.","volume":"59","author":"Marcelli","year":"1999","journal-title":"Cancer Res"},{"key":"R32-4-20210130","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/1097-0142(19941201)74:11<3051::AID-CNCR2820741124>3.0.CO;2-P","article-title":"Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma: a report of two cases and a review of the literature.","volume":"74","author":"McCarty","year":"1994","journal-title":"Cancer"},{"key":"R33-4-20210130","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood.V96.13.4307","article-title":"Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.","volume":"96","author":"Mir","year":"2000","journal-title":"Blood"},{"key":"R34-4-20210130","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V94.9.3077","article-title":"CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: a clue to the pathophysiology of clinical regression.","volume":"94","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"R35-4-20210130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.267.5196.316-b","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkins lymphoma.","volume":"267","author":"Morris","year":"1995","journal-title":"Science"},{"key":"R36-4-20210130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor.","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"R37-4-20210130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-2133.2001.04523.x","article-title":"Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.","volume":"145","author":"Nevala","year":"2001","journal-title":"Br J Dermatol"},{"key":"R38-4-20210130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0046-8177(98)90249-0","article-title":"Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily.","volume":"29","author":"Paulli","year":"1998","journal-title":"Hum Pathol"},{"key":"R39-4-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/path.1346","article-title":"BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.","volume":"200","author":"Rassidakis","year":"2003","journal-title":"J Pathol"},{"key":"R40-4-20210130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1309\/HKMV-VMPP-0CH8-3DPQ","article-title":"Apoptotic rate in peripheral T-cell lymphomas: a study using a tissue microarray with validation on full tissue sections.","volume":"118","author":"Rassidakis","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R41-4-20210130","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood.V94.8.2854.420k07_2854_2861","article-title":"A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma.","volume":"94","author":"Schiemann","year":"1999","journal-title":"Blood"},{"key":"R42-4-20210130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/modpathol.3880076","article-title":"Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.","volume":"13","author":"Sigel","year":"2000","journal-title":"Mod Pathol"},{"key":"R43-4-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s004410000203","article-title":"Detection of apoptosis in tissue sections.","volume":"301","author":"Stadelmann","year":"2000","journal-title":"Cell Tissue Res"},{"key":"R44-4-20210130","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.","volume":"75","author":"Suda","year":"1993","journal-title":"Cell"},{"key":"R45-4-20210130","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1182\/blood.V99.12.4540","article-title":"Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.","volume":"99","author":"ten Berge","year":"2002","journal-title":"Blood"},{"key":"R46-4-20210130","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/sj.onc.1206399","article-title":"Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells.","volume":"22","author":"Tourneur","year":"2003","journal-title":"Oncogene"},{"key":"R47-4-20210130","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1240::AID-CNCR19>3.0.CO;2-X","article-title":"Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis.","volume":"86","author":"Wang","year":"1999","journal-title":"Cancer"},{"key":"R48-4-20210130","first-page":"8563","article-title":"Harnessing apoptosis for improved anticancer gene therapy.","volume":"63","author":"Waxman","year":"2003","journal-title":"Cancer Res"},{"key":"R49-4-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1022554824129","article-title":"Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.","volume":"61","author":"Weaver","year":"2003","journal-title":"J Neurooncol"},{"key":"R50-4-20210130","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood.V86.6.2321.bloodjournal8662321","article-title":"Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkins lymphomas of T-cell phenotype, and in Hodgkins disease.","volume":"86","author":"Wellmann","year":"1995","journal-title":"Blood"},{"key":"R51-4-20210130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(93)70140-O","article-title":"Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment.","volume":"28","author":"Willemze","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R52-4-20210130","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"R53-4-20210130","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V88.5.1765.1765","article-title":"Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkins disease.","volume":"88","author":"Wood","year":"1996","journal-title":"Blood"},{"key":"R54-4-20210130","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/sj.gt.3301041","article-title":"Cancer gene therapy using a pro-apoptotic gene, caspase-3.","volume":"6","author":"Yamabe","year":"1999","journal-title":"Gene Ther"},{"key":"R55-4-20210130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1067\/S0190-9622(03)01577-9","article-title":"Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality.","volume":"49","author":"Zackheim","year":"2003","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007632-200503150-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:42:17Z","timestamp":1785850937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-200504000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pas.0000155154.46434.93","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}